An Evaluation of the Efficacy and Safety of E2007 in Patients With Painful Diabetic Neuropathy

NCT00505284 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

352

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Neuropathy

Interventions

DRUG: Placebo
DRUG: E2007 (2 mg)
DRUG: E2007 (4 mg)
DRUG: E2007 (6 mg)
DRUG: E2007 (8 mg)

Sponsor

Eisai Inc.

Collaborators

[object Object]